Scholars@Duke publication: Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.

Journal cover image

Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.

Publication , Journal Article

Riedel, RF; Crawford, J; Dunphy, F; Herndon, JE; Garst, J; Kelley, MJ

Published in: Lung Cancer

December 2006

Published version (DOI) Link to item

Duke Scholars

Author Richard Francis Riedel Medicine, Medical Oncology

Author Jeffrey Crawford Medicine, Medical Oncology

Author James Emmett Herndon II Biostatistics & Bioinformatics, Division of Biostatistics

Author Jennifer Lynn Garst Medicine, Medical Oncology

Author Michael John Kelley Medicine, Medical Oncology

Published In

Lung Cancer

DOI

10.1016/j.lungcan.2006.08.008

ISSN

0169-5002

Publication Date

December 2006

Volume

54

Issue

3

Start / End Page

431 / 432

Location

Ireland

Related Subject Headings

Treatment Outcome
Thalidomide
Oncology & Carcinogenesis
Middle Aged
Male
Lung Neoplasms
Irinotecan
Humans
Female
Carcinoma, Small Cell

Citation

APA

Chicago

ICMJE

MLA

NLM

Riedel, R. F., Crawford, J., Dunphy, F., Herndon, J. E., Garst, J., & Kelley, M. J. (2006). Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer. Lung Cancer, 54(3), 431–432. https://doi.org/10.1016/j.lungcan.2006.08.008

Riedel, Richard F., Jeffrey Crawford, Frank Dunphy, James E. Herndon, Jennifer Garst, and Michael J. Kelley. “Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.” Lung Cancer 54, no. 3 (December 2006): 431–32. https://doi.org/10.1016/j.lungcan.2006.08.008.

Riedel RF, Crawford J, Dunphy F, Herndon JE, Garst J, Kelley MJ. Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer. Lung Cancer. 2006 Dec;54(3):431–2.

Riedel, Richard F., et al. “Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.” Lung Cancer, vol. 54, no. 3, Dec. 2006, pp. 431–32. Pubmed, doi:10.1016/j.lungcan.2006.08.008.

Riedel RF, Crawford J, Dunphy F, Herndon JE, Garst J, Kelley MJ. Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer. Lung Cancer. 2006 Dec;54(3):431–432.

Journal cover image

Published In

Lung Cancer

DOI

10.1016/j.lungcan.2006.08.008

ISSN

0169-5002

Publication Date

December 2006

Volume

54

Issue

3

Start / End Page

431 / 432

Location

Ireland

Related Subject Headings

Treatment Outcome
Thalidomide
Oncology & Carcinogenesis
Middle Aged
Male
Lung Neoplasms
Irinotecan
Humans
Female
Carcinoma, Small Cell